Pimpri Police Arrest Medical Shop Owner For Selling Fake Cancer Injections, Seizes Rs 3.5 Lakh Worth Drugs

Pimpri: The Pimpri police have arrested a medical shopkeeper involved in manufacturing and selling counterfeit cancer injections that were not approved for sale in India. The arrested individual has been identified as Shriprasad Shrihari Kulkarni, a 42-year-old resident of Rohan Radhika Apartment, near Prathamesh Nagri, Sun City, Sinhagad Road. Authorities have seized two boxes of fake cancer injections worth Rs 3.5 lakh from him, each of which he sold for Rs 1 lakh.

The case came to light after Mahesh Vishnu Kamble, a 42-year-old resident of Janwadi, lodged a complaint with the Pimpri police. According to the police, the injection in question, Adcetris, produced by TAKEDA Pharmaceutical Ltd. for cancer treatment, is not manufactured for sale in India. The pharmaceutical company informed Kamble that Kulkarni had been selling counterfeit versions of the drug in Pune.

Further, the plaintiff learnt that the accused was selling the drugs only to cancer patients. Therefore, to verify the allegations, a woman with cancer was asked to place an order for two injections. Kulkarni charged her Rs 2 lakh for the fake injections. The woman sent the injections to the pharmaceutical company for verification, which, after the examination, confirmed that they were counterfeit.

Accordingly, Kamble then reported the incident to Pimpri police. In a subsequent operation, the woman again placed an order for two injections. Kulkarni was apprehended when he came to deliver the fake injections at Niramay Hospital. During the search, police found two boxes of counterfeit injections valued at Rs 3.5 lakh. Assistant Police Inspector Dr. Ashok Dongre is leading the ongoing investigation into the matter.

Related Posts

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform